Literature DB >> 10501241

Evaluation of a 74-kDa transferrin-binding protein from Moraxella (Branhamella) catarrhalis as a vaccine candidate.

D Chen1, J C McMichael, K R VanDerMeid, A W Masi, E Bortell, J D Caplan, D N Chakravarti, V L Barniak.   

Abstract

An outer membrane protein from Moraxella catarrhalis with a mass of 74-kDa was isolated and evaluated as a vaccine candidate. The 74-kDa protein binds transferrin, and appears to be related to the other proteins from the organism that are reported to bind transferrin. The 74-kDa protein possessed conserved epitopes exposed on the bacterial surface. This is based on the reactivity with whole bacterial cells as well as complement dependent bactericidal activity of sera from mice immunized with the isolated proteins from the O35E and TTA24 isolates. However, there was divergence in the degree of antibody cross-reactivity with the protein from one strain to another. This serotypic divergence was reflected in both the complement-dependent bactericidal activities of the antibodies elicited in mice and the capacity of immune mice to clear the bacteria in a murine pulmonary model. Antibodies affinity purified from human plasma lacked bactericidal activity even though they were reactive with all the tested isolates. The 74-kDa protein appears to be a good vaccine candidate, but more studies are needed to understand its antigenic variability and whether antibodies toward it are protective.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10501241     DOI: 10.1016/s0264-410x(99)00188-7

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

Review 1.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

2.  Synthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis.

Authors:  Shengqing Yu; Xin-Xing Gu
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

3.  The Moraxella catarrhalis autotransporter McaP is a conserved surface protein that mediates adherence to human epithelial cells through its N-terminal passenger domain.

Authors:  Serena L Lipski; Christine Akimana; Jennifer M Timpe; R Mark Wooten; Eric R Lafontaine
Journal:  Infect Immun       Date:  2006-11-06       Impact factor: 3.441

Review 4.  A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

5.  Characterization of proteins Msp22 and Msp75 as vaccine antigens of Moraxella catarrhalis.

Authors:  Elizabeth A Ruckdeschel; Aimee L Brauer; Antoinette Johnson; Timothy F Murphy
Journal:  Vaccine       Date:  2009-09-26       Impact factor: 3.641

6.  Mining the Moraxella catarrhalis genome: identification of potential vaccine antigens expressed during human infection.

Authors:  Elizabeth A Ruckdeschel; Charmaine Kirkham; Alan J Lesse; Zihua Hu; Timothy F Murphy
Journal:  Infect Immun       Date:  2008-01-28       Impact factor: 3.441

7.  The Moraxella catarrhalis porin-like outer membrane protein CD is an adhesin for human lung cells.

Authors:  Melissa M Holm; Serena L Vanlerberg; Ian M Foley; Darren D Sledjeski; Eric R Lafontaine
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

8.  Studies on resistance characteristic and cDNA sequence conservation of transferrin from crucian carp, Carassius auratus.

Authors:  Hua Long; Qi-Xing Yu
Journal:  Mol Cell Biochem       Date:  2007-07-24       Impact factor: 3.842

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.